|
Symbol
|
RMA53V | RMAFAV | RMBWZV | KSADDU | RMAVHV | RMAEHV | OBORCH | OHMRCH | OGQRCH | RMAZ7V | AACXTQ | RMAFFV | BZIBKB | RMA93V | RMBA5V | OOWRCH | OPRRCH | CBRBKB | RMBAQV | AAPGTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible |
|
Basiswert
|
Lonza Group N / Novartis AG / Sandoz Group AG | CREDIT SUISSE UBS MERGER / Ems-Chemie Hldg. AG / Sandoz Group AG | Novartis AG / Novo Nordisk AS (B) / Sandoz Group AG | Sandoz Group AG / Sonova Hldg. AG / Straumann Hldg. AG | Alcon / Novartis AG / Sandoz Group AG / Siegfried Hldg. AG | Alcon / Novartis AG / Sandoz | Roche AG / Sandoz Group AG / Straumann Hldg. AG | Alcon / Sandoz Group AG / Straumann Hldg. AG | Novartis AG / Sandoz Group AG / Straumann Hldg. AG | Alcon / Lonza Group N / Novartis AG / Sandoz Group AG | Alcon / Sandoz Group AG / Straumann Hldg. AG | Alcon / Galderma Group AG / Sandoz Group AG | Alcon / Novartis AG / Sandoz | Alcon / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG | Alcon / Sandoz Group AG / Straumann Hldg. AG | Novartis AG / Roche AG / Sandoz Group AG / Swisscom N / Zurich Insurance Group AG | Alcon / Sandoz Group AG / Straumann Hldg. AG | Nestlé S.A. / Novartis AG / Roche AG / Sandoz Group AG / Straumann Hldg. AG | Clariant AG / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
23.02.2026 | 09.03.2026 | 16.03.2026 | 17.04.2026 | 30.03.2026 | 20.04.2026 | 22.04.2026 | 03.06.2026 | 27.05.2026 | 15.06.2026 | 17.06.2026 | 29.06.2026 | 08.07.2026 | 12.01.2027 | 05.01.2027 | 22.04.2026 | 26.01.2027 | 02.11.2026 | 09.02.2027 | 12.08.2026 |
| Geld | - | 68.40 | 33.200 | - | 99.90 | 98.60 | 92.36 | 99.85 | 101.32 | 99.10 | 99.49 | 92.70 | 96.67 | 98.30 | 97.60 | 99.37 | 99.21 | 92.13 | 94.70 | 63.81 |
| Brief | - | - | - | - | 100.90 | 99.60 | - | - | - | 99.90 | - | 93.50 | - | 99.10 | 98.40 | - | 100.01 | - | 95.70 | - |